片形吸虫排泄分泌产物的研究进展

doi:10.11843/j.issn.0366-6964.2017.02.002

畜牧兽医学报 ›› 2017, Vol. 48 ›› Issue (2): 201-206.doi: 10.11843/j.issn.0366-6964.2017.02.002

片形吸虫排泄分泌产物的研究进展

田艾灵，朱兴全，黄思扬^*

（中国农业科学院兰州兽医研究所家畜疫病病原生物学国家重点实验室甘肃省动物寄生虫病重点实验室，兰州 730046）

收稿日期:2016-08-15 出版日期:2017-02-23 发布日期:2017-02-23
通讯作者: 黄思扬，Tel：0931-8342716，E-mail：huangsiyang@caas.cn
作者简介:田艾灵(1993-)，女，重庆人，硕士生，主要从事动物寄生虫及其分子生物学方面的研究，E-mail：404883157@qq.com
基金资助:
国家重点基础研究发展计划（973计划）（2015CB150300）

Research Advances in Excretory-secretory Products of Fasciola spp.

TIAN Ai-ling，ZHU Xing-quan，HUANG Si-yang^*

（State Key Laboratory of Veterinary Etiological Biology/Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China）

Received:2016-08-15 Online:2017-02-23 Published:2017-02-23

摘要/Abstract

摘要：

片形吸虫病（fascioliasis）是由片形吸虫（Fasciola spp.）感染而引起的一种人兽共患寄生虫病，能引起动物“大批死亡”，是影响全球公共卫生和畜牧业经济发展的重要问题。片形吸虫在与宿主长期互作过程中，产生抵抗宿主免疫应答的方法得以在宿主体内保存下来，而片形吸虫生长发育的各个时期的排泄分泌产物（excretory-secretory products，ESP）在其中发挥了重要作用，ESP按功能大致分为氧化应激相关蛋白、能量代谢相关蛋白和蛋白酶体相关蛋白三类。在片形吸虫的免疫逃避中，ESP也发挥了重要作用。因此本文中笔者对其进行综述，旨在为研制新型疫苗或药物提供参考。

Abstract:

Fascioliasis is a sort of zoonotic disease caused by Fasciola spp., which can cause a large number of deaths in animals. It is considered to be a major problem for effecting on global public health and husbandry economic development. The method of resistance of host immune response that can survive in the host during the process of long-term mutual struggle between Fasciola spp. and its host. However, the excretory-secretory products (ESP) in different developmental stages of Fasciola spp. play a significant role in this process. In fact, ESP can be divided into oxidative stress related proteins, proteins related to energy metabolism and the proteasome associated proteins according to the functions. The ESP play important roles in the immune evasion of the Fasciola spp. Therefore, this dissertation expounded its functions with the purpose of providing implications for the research of new vaccines or drugs.

中图分类号:

S852.735

田艾灵，朱兴全，黄思扬. 片形吸虫排泄分泌产物的研究进展[J]. 畜牧兽医学报, 2017, 48(2): 201-206.

TIAN Ai-ling，ZHU Xing-quan，HUANG Si-yang. Research Advances in Excretory-secretory Products of Fasciola spp.[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2017, 48(2): 201-206.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.xmsyxb.com/CN/10.11843/j.issn.0366-6964.2017.02.002

https://www.xmsyxb.com/CN/Y2017/V48/I2/201

参考文献

［1］MAS-COMA S, BARGUES M D, VALERO M A. Fascioliasis and other plant-borne trematode zoonoses［J］. Int J Parasitol, 2005, 35(11-12): 1255-1278.
［2］MEEMON K, SOBHON P. Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies［J］. Parasitol Res, 2015, 114(8): 2807-2813.
［3］PIEDRAFITA D, SPITHILL T W, SMITH R E, et al. Improving animal and human health through understanding liver fluke immunology［J］. Parasite Immunol, 2010, 32(8): 572-581.
［4］World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation-executive summary［R/OL］. Geneva, Switzerland: World Health Organization， 2012. ［2014-1-20］. http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.
［5］World Health Organization. The “neglected” neglected worms［J/OL］. Action against worms, 2007(10): 1. ［2016-12-12］.http://www.who.int/neglected_diseases/preventive_chemotheropy/Newsletters10.pdf.
［6］World Health Organization. Report of the WHO informal meeting on use of triclabendazole in fascioliasis control［R/OL］. WHO headquarters, Geneva, Switzerland, 17-18 October 2006. World Health Organization, Geneva. ISBN 92 4 154638 7. ［2016-12-12］http://www.who.int/neglected_diseases/preventive_chemotherapy/WHO_CDS_NTD_PCT_2007.1.pdf.
［7］ALASAAD S, SORIGUER R C, ABU-MADI M, et al. A TaqMan real-time PCR-based assay for the identification of Fasciola spp.［J］. Vet Parasitol, 2011, 179(1-3): 266-271.
［8］MAS-COMA S, VALERO M A, BARGUES M D. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control［J］. Adv Parasitol, 2009, 69: 41-146.
［9］MAS-COMA S, VALERO M A, BARGUES M D. Fascioliasis［J］. Adv Exp Med Biol, 2014, 766: 77-114.
［10］ROBINSON M W, DALTON J P, O'BRIEN B A, et al. Fasciola hepatica: the therapeutic potential of a worm secretome［J］. Int J Parasitol, 2013, 43(3-4): 283-291.
［11］JEFFERIES J R, CAMPBELL A M, VAN ROSSUM A J, et al. Proteomic analysis of Fasciola hepatica excretory-secretory products［J］. Proteomics, 2001, 1(9): 1128-1132.
［12］BOUKLI N M, DELGADO B, RICAURTE M, et al. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis［J］. J Parasitol, 2011, 97(5): 852-861.
［13］GOURBAL B E, GUILLOU F, MITTA G, et al. Excretory-secretory products of larval Fasciola hepatica investigated using a two-dimensional proteomic approach ［J］. Mol Biochem Parasitol, 2008, 161(1): 63-66.
［14］BIENERT G P, SCHJOERRING J K, JAHN T P. Membrane transport of hydrogen peroxide［J］. Biochim Biophys Acta, 2006, 1758(8): 994-1003.
［15］ROBINSON M W, DALTON J P. Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases［J］. Philos Trans R Soc Lond B Biol Sci, 2009, 364(1530): 2763-2776.
［16］CHANGKLUNGMOA N, KUEAKHAI P, APISAWETAKAN S, et al. Identification and expression of Fasciola gigantica thioredoxin［J］. Parasitol Res, 2014, 113(6): 2335-2343.
［17］HOLMGREN A, JOHANSSON C, BERNDT C, et al. Thiol redox control via thioredoxin and glutaredoxin systems［J］. Biochem Soc Trans, 2005, 33(Pt 6): 1375-1377.
［18］ALIRAHMI H, FARAHNAK A, GOLMOHAMADI T, et al. Comparative assay of glutathione S-transferase (GSTs) activity of excretory-secretory materials and somatic extract of Fasciola spp. parasites［J］. Acta Med Iran, 2010, 48(6): 367-370.
［19］PREYAVICHYAPUGDEE N, SAHAPHONG S, RIENGROIPITAK S, et al. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase(rFgGST26) against infections in mice［J］. Exp Parasitol, 2008, 119(2): 229-237.
［20］MARTIN I, CABÁN-HERNÁNDEZ K, FIGUEROA-SANTIAGO O, et al. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo［J］. J Immunol, 2015, 194(8): 3924-3936.
［21］MORPHEW R M, WRIGHT H A, LA-COURSE E J, et al. Comparative proteomics of excretory-secretory proteins released by the liver fluke Fasciola hepatica in sheep host bile and during in vitro culture ex host［J］. Mol Cell Proteomics, 2007, 6(6): 963-972.
［22］MAHANA N, ABD-ALLAH H A, SALAH M, et al. Fasciola gigantica enolase is a major component of worm tegumental fraction protective against sheep fasciolosis［J］. Acta Trop, 2016, 158: 189-196.
［23］DE GUZMAN J V, YU H S, JEONG H J, et al. Molecular characterization of two myoglobins of Paragonimus westermani［J］. J Parasitol, 2007, 93(1): 97-103.
［24］DEWILDE S, IOANITESCU A I, KIGER L, et al. The hemoglobins of the trematodes Fasciola hepatica and Paramphistomum epiclitum: a molecular biological, physico-chemical, kinetic, and vaccination study［J］. Protein Sci, 2008, 17(10): 1653-1662.
［25］ROBINSON M W, MENON R, DONNELLY S M, et al. An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host［J］. Mol Cell Proteomics, 2009, 8(8): 1891-1907.
［26］CHANTREE P, PHATSARA M, MEEMON K, et al. Vaccine potential of recombinant cathepsin B against Fasciola gigantica［J］. Exp Parasitol, 2013, 135(1): 102-109.
［27］CWIKLINSKI K, DALTON J P, DUFRESNE P J, et al. The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution［J］. Genome Biol, 2015, 16: 71.
［28］SANSRI V, CHANGKLUNGMOA N, CHAICHANASAK P, et al. Molecular cloning, characterization and functional analysis of a novel juvenile-specific cathepsin L of Fasciola gigantica［J］. Acta Trop, 2013, 128(1): 76-84.
［29］CANCELA M, ACOSTA D, RINALDI G, et al. A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica［J］. Biochimie, 2008, 90(10): 1461-1475.
［30］DONNELLY S, STACK C M, O’NEILL S M, et al. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages［J］. FASEB J, 2008, 22(11): 4022-4032.
［31］FLYNN R J, MANNION C, GOLDEN O, et al. Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis［J］. Infect Immun, 2007, 75(3): 1373-1381.
［32］罗洪林，张为宇，黄维义.大片吸虫组织蛋白酶L全长序列的获取及其生物信息学分析［J］.畜牧兽医学报，2008，39（2）：206-211.
LUO H L， ZHANG W Y, HUANG W Y. Isolation and bioinformatic analysis of Full-length catepsin L Gene［J］. Acta Veterinaria et Zootechnica Sinica， 2008，39（2）：206-211.（in Chinese）
［33］PÉREZ-SÁNCHEZ R, RAMAJO-HERNANDEZ A, RAMAJO-MARTIN V, et al. Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms［J］. Proteomics, 2006, 6（Suppl 1）: S226-236.

[1]	钟昊然, 侯玲, 桂祥, 吕荣雪, 刘金明, 古少鹏, 金亚美. HMGB1与日本血吸虫病肝炎症和纤维化的相关性分析[J]. 畜牧兽医学报, 2022, 53(10): 3609-3620.
[2]	张媛媛, 许蓉, 何川川, 李肖纯, 程贵凤, 郭露, 刘金明, 李浩, 古少鹏, 金亚美. 日本血吸虫ELAV-like 2基因的克隆、表达及功能分析[J]. 畜牧兽医学报, 2018, 49(9): 1987-1997.
[3]	邢凤，梁志朋，李成林. 实验感染肝片吸虫和田羊和中国美利奴羊绵羊免疫反应[J]. 畜牧兽医学报, 2015, 46(3): 445-452.

片形吸虫排泄分泌产物的研究进展

Research Advances in Excretory-secretory Products of Fasciola spp.

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价